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ODN (18mar) was inj~Joted with the PB (n = 7) at 4 arm inflation pressure for 
30 s: with the IO (n = 3) ODN was applied with 7.5 mA corrent for 3 x 60 
s. Parallel studies were peffom'ted esing dled~mine labelled ODN (rhoOON) 
for histotegi(~ Io¢~alk~n. Samples were harvested at 30 rnln. 2 h, 24 h 
and 7 d and processed for scir~'ilation counting or fluoreecance m/cmscopy. 
Results: 
~g ODN per anefy 
PB 570 ~'gh~ 3.45 -t- ! .3 1,42 + 0.65 0.ca + 0.02 ND 
IO 855 pg/~,  7.3±P-4 1,5 ~" 0.6 0.52 =b 0.35 0.26:E D.11 
n. 3lgroup:data are mean :~ SEM 
While 1(3 ~ to dern~" more than PB acutely, there was rapid 
w,~shout at 2 h in beth groups. However, after 24 h persistence appeared 
better with the IO, and in one sample there was persistence at 7 d with IO. 
This may hm~ been in part dec tu impreved tissue distribetion and cetlular 
t .q~e "~'h tO, which was detected with d~oOON. 
Concfus/o~: Io,~tot~horesis appears superior tO PB for LD of ODN in pt9 
coronary artedas and may be feasible for restenosls prevention in the dlnical 
setting. 
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Jean Gregsire, Michael E.. Stasb, Sanjay S. Sdvatsa, Dmtk:l R. Holmes, 
Robert S. SchwartT- Mayo Clinic, Rochester, MN 55905 
Nitric oxide {NO) is an endothelial.derived vasodilator and anti-platalet ag- 
g reen  factor. We studied local delivery of a novel NO donor in pigs after 
severe carotid artery crush ~ury. In v~o quantitative platelet deposition (PD) 
was measured by 111-1n tmpolone labeled platalets, and normalized blood 
flew (NBF) measured by Doppler ftowmetry, Local arterial infusion of the 
NO donor daesy~p;perazine onoats (GLOMO) was compared ~ conlml 
(saline), infused identically by the Dispatch catheter. Four groups were stud- 
ied: A (10 arteries): injury, local saline, B (10 arteries): injury, local GLO/NO 
(10 ml/3 x 10 ..4 tool over 10 rain), C (9 arteries): injury, systemic G LO/NO (3 
~< 10 ..4 tool), D (6 arteries): injury, systsmio GLO/NO, local saline. Each was 
studied at t and 24 hours. 
Group 
TTme ~r) 
Patency (%) 
NBF 
PD (x 10s/cn~ -) 
A B G D 
1 24 1 24 1 24 1 24 
80 60 90" 90 # 33 ° 11 # 83 66 
0.25" 0.28" 0.73" 0.75" 0.18" 0.07* 0.59 0.13 
5.5 + P..2" 1.3 :E 0A* 4.9 ~: 1.0" 7.6 d: 3.1 
*p < 0.05: Group Avs B, Group Bvs C, #p < 0.005: Group 0 vs C 
Conclusion: Local NO delivery signifoantly reduces occlusion and pletelet 
deposition after severe artedal injury. This underscores the role of NO as 
a modulator of vascular tone and thrembus formation, and suggests an 
effective therapeutic strategy following angioplasty. 
~ l n  Vitro Model to Investigate Stem Activated 
Platelets by Row Cytometry 
Christian Beythien 1 Kai Gutensohn =, Wolfram Terms ~, Christian 
1 2 % 1 W. Hamm , Peter K0hnl , Thomas Malneriz . Dept. of Cardiology, 
University Hospital F_.ppendoff, Hamburg, Germany: ~ Dept. of Transfusion 
Medicine and Transplantation Immunology, University Hospital Eppendoff, 
Hamburg, Germany 
The applicatiOn of stents in coronary arteries is still limited by acute or subs- 
cute occlusion. Acth~ted pletalets play a major role in thrombes formation. In 
an in vitro model of stent hrombosis we investigated the expression of activa- 
tion dependent glycoproteins (GP) on platelets by flow cytometry. Tantalum 
wire stants (n = 12) were placed in one of two parattel silicon tubings with 
circulating citrated ptstelet rich ptesma of healthy and drug free volunteers. 
Over 10 minutes aliquots ot platelet dch plasma were drawn via a three way 
faucet In two minute intervals. Blood samples were immediately fixed with 
glyoxal, paraforrnaldehyde and buffer. For flow oytome~c ~nalysis mono- 
cional antibodies C041~ (GPIIb/llla), CD42b (GPIb}, CD62 (GMP-140) and 
CD63 (GP63) were used. 10,000 events were acquired in a life gate setting. 
Results were expressed as "pletelet activation" (PAl Rinder, Transfusion 33, 
1993). W'~hin 2 minutes after the start of circulation, the expression of CD62 
and C063 increased in the tubing system with the stent. Over 10 minutes 
platelet activation progressively increased; CD62 1051 ::t: 548 vs 359 .-E 358 
PA control without stentS (p < 0.01) and C063 981 ~ 355 vs 428 d: 156 PA 
(p < 0.005). Antigens cD41a and CD42b did not show signif/cant changes. 
Thus, in our in vitro model there is activation of platelets by slants probably 
caused by shear stress and contact to the artificial surface, Flow cytomeW 
is a diagnostic tool to quantify platalet activation, and may help to improve 
etent matsdal and design. 
~ Photodynaml¢ Therapy end Local Drug Delivery In 
a ReMenceis Model 
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Photodynamio therapy (PDT) was examined in porcine restenosts model. 
Unidirectional injury of media by a atherectemc atheter (UI) was used, The 
photasensitizet, Photeffln (PF; QLT, Canada) was delivered with a new nee- 
dle injection catheter (NIC) and activated by adequate monochromatic light 
irradiation. 46 artsdal segments from ptgs (mean weight 34 kg) underwent 
UI and were removed at 7, 14 or 21 days. 16 vessel segments received no 
further treatment (Group 1 ); 12 segments received U| and local drug delivery 
or monochromatic light exposure. (Group 2 and 3) 28 segments unden~ent 
U! followed by selective application of 5 rng PF per treated segment and 
expOsure to monochromatic light with a light delivery catheter (630 nm) with 
100 J/cm2 (Group 4, therapeutic group). Aif vessels were explanted and 
processed for immunohistochemistry and electron microscopy. 
Group 1: An intense inflammation with polymorphonuclear leukocytas and 
subsequent proliferation of myoflbreblasts (maximum after 7 d) was found. 
After substantial vessel injury only (Group 1), a myoproliferative r sponse 
resulted in tissue hyperplasia of 1.8 ± mrn ~. Group 2 and 3 results did not 
reveal significant differences to group 1, In media-injured vessels treated with 
PDT, no inflammation and or proliferative response resulted (area of tissue 
hyperplasia 0.3 mn'~.). A marked destruction of nuclear membranes with PF 
deposits in smooth muscle coils with cytoplasmatic vacuoles were seen after 
PDT. These results were only seen with laser application after PF delivery. 
There were no alterations in nuclear morphology. 
Thus, after selective application of a photesansitizer, local PDT led to a 
marked reduction of proliferation and tissue hyperplasla in a porcine model 
of restenosis without adveme effects. 
~ Efficiency of  Coronary  Drug Delivery With the 
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Local delivery of antiphlegistic/proliferative agents might prevent or protract 
restenosis development. To date local drug delivery is hampered by tow 
local efficiency and adjacent tissue contamina,'idn. A new designed over- 
the-wire needle injection catheter (NIG) for coronary application was used. 
C14-1abefled Cawedilci (molecular weight 400) or Benzoporphydnderivative 
(BPD) was tested in normal coronary and femoral porcine arteries (n = 19). 
The NIC system was used for drug delivery of either 0.3 mg or 0.03 mg C ~4- 
Carvedilci (Group 1) or 2 mg BPD (Group 2). Vessels were removed up to 4 
hours after drug delivery. Determination of drug content was performed after 
homngenisetion of vessel tissue in ascintilletion counter (combustion) or by 
chromatography. There were no .eigniticant differences in the results between 
0.3 mg or 0.03 mg C14-Carvedilol or in the anolyzetion methods (Group 1 
or 2). The maximum content could be detected at 2 hours (14.2.4- 1.2% of 
total drug amount) in perivascular tissue (media 1-2.5%) with a decrease 
thereafter (to 2.9 ± 01%). There was contamination of pe~ascular tissue, 
as ascertained by enhanced drug content (maximum 0.3~o of total drug 
amount immediately after drug delivery). No systemic ontent was measured 
after local drug delivery with the NIC; there was no measurable renal, hepatic 
or splenic drug content. 
In conclusion, local drug delivery into arterial vessel wall is feasible us- 
ing the new needle injection catheter system, tt allows.a higher efficiency, 
with pmloeged delivery compared with data available relating to other local 
drug delivery systems. Adjacent tissue contamination must be taken into 
consideration. 
9~8-4-- '~ Local Delivery o f  Lipid.Complexed Ol lgonucleot ide 
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Localized delivery (LD) of conventional drugs, gane constructs, and oligonu- 
cteotldes (ODN) is a potential means to prevent ialrogenic restenosis and 
thrombosis after vascular interventions. Problems with this technology in- 
